XML 99 R94.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Supplemental Guarantor Information (Supplemental Condensed Consolidated Statement Of Cash Flows) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities $ (68,807) $ (195,578) $ (111,272)
Net cash used in investing activities (14,283) (43,536) (134,446)
Financing activities      
Borrowings under revolving credit facilities 1,548,500 721,000 175,000
Payments on revolving credit facilities (1,682,300) (518,500) (370,000)
Proceeds from issuance senior notes 500,000   527,500
Extinguishment of senior notes due 2022 (391,942)    
Principal payments on notes payable (20,237) (5,371) (6,998)
Proceeds from insurance notes payable 13,719 11,839 2,320
Extinguishments of debt assumed in business combination   (94,231) (151,919)
Debt issuance costs (6,140) (3,642) (8,579)
Net proceeds from mortgage repurchase facilities 69,540 56,236 48,320
Net proceeds from issuances of common stock 79,052 30,947 98,063
Repurchases of common stock upon vesting of stock-based compensation (3,583) (5,484) (5,231)
Repurchases of common stock under our stock repurchase program (1,439) (10,952)  
Net cash provided by (used in) financing activities 105,170 181,842 308,476
Net increase (decrease) 22,080 (57,272) 62,758
Cash and cash equivalents and Restricted cash, Beginning of period 36,441 93,713 30,955
Cash and cash equivalents and Restricted cash, End of period 58,521 36,441 93,713
Cash and cash equivalents 55,436 32,902 88,832
Restricted Cash 3,085 3,539 4,881
Elimination Entries [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash used in investing activities (17,153) 226,310 440,949
Financing activities      
Payments from (and advances to) parent/subsidiary 17,153 (226,310) (440,949)
Net cash provided by (used in) financing activities 17,153 (226,310) (440,949)
Parent      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities (54,572) (74,074) (27,787)
Net cash used in investing activities 11,818 (98,523) (456,299)
Financing activities      
Borrowings under revolving credit facilities 1,548,500 721,000 175,000
Payments on revolving credit facilities (1,682,300) (518,500) (370,000)
Proceeds from issuance senior notes 500,000   527,500
Extinguishment of senior notes due 2022 (391,942)    
Principal payments on notes payable   (9)  
Extinguishments of debt assumed in business combination   (94,231)  
Debt issuance costs (6,140) (3,642) (8,579)
Net proceeds from issuances of common stock 79,052 30,947 98,063
Repurchases of common stock upon vesting of stock-based compensation (3,583) (5,484) (5,231)
Repurchases of common stock under our stock repurchase program (1,439) (10,952)  
Payments from (and advances to) parent/subsidiary   (583) 108,930
Net cash provided by (used in) financing activities 42,148 118,546 525,683
Net increase (decrease) (606) (54,051) 41,597
Cash and cash equivalents and Restricted cash, Beginning of period 2,183 56,234 14,637
Cash and cash equivalents and Restricted cash, End of period 1,577 2,183 56,234
Cash and cash equivalents 1,577 2,183 56,234
Guarantor Subsidiaries [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities 51,793 (71,532) (33,169)
Net cash used in investing activities (8,815) (170,862) (118,583)
Financing activities      
Principal payments on notes payable (20,237) (5,362) (6,998)
Proceeds from insurance notes payable 13,719 11,839 2,320
Extinguishments of debt assumed in business combination     (151,919)
Payments from (and advances to) parent/subsidiary (40,126) 211,879 326,242
Net cash provided by (used in) financing activities (46,644) 218,356 169,645
Net increase (decrease) (3,666) (24,038) 17,893
Cash and cash equivalents and Restricted cash, Beginning of period 4,006 28,044 10,151
Cash and cash equivalents and Restricted cash, End of period 340 4,006 28,044
Cash and cash equivalents   2,101 23,399
Restricted Cash 340 1,905 4,645
Non Guarantor Subsidiaries [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities (66,028) (49,972) (50,316)
Net cash used in investing activities (133) (461) (513)
Financing activities      
Net proceeds from mortgage repurchase facilities 69,540 56,236 48,320
Payments from (and advances to) parent/subsidiary 22,973 15,014 5,777
Net cash provided by (used in) financing activities 92,513 71,250 54,097
Net increase (decrease) 26,352 20,817 3,268
Cash and cash equivalents and Restricted cash, Beginning of period 30,252 9,435 6,167
Cash and cash equivalents and Restricted cash, End of period 56,604 30,252 9,435
Cash and cash equivalents 53,859 28,618 9,199
Restricted Cash $ 2,745 $ 1,634 $ 236